beta‐lactam monotherapy vs beta‐lactam (cloxacillin) plus aminoglycoside (gentamicin)
All cause mortality · people with cancer who have febrile neutropenia
beta‐lactam monotherapy showed no clear difference in all cause mortality compared with beta‐lactam‐aminoglycoside combination therapy (high certainty).
1 finding from 1 review
- Beta‐lactam versus beta‐lactam‐aminoglycoside combination therapy in cancer patients with neutropenia 2013 · Cochrane Headline outcomes onlyRR 0.87 [0.75, 1.02]44 studies · 7186 participantsHigh